文献速递性腺与生殖内分泌垂体与肾上腺疾病

RNF216变异通过自噬失调导致HH合并共济失调与痴呆

RNF216 Variants Found in Patients With Dementia, Hypogonadotropic Hypogonadism, and Severe Ataxia Deregulate Autophagy.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

在1476例低促性腺激素性性腺功能减退症(HH)患者中,外显子分析发现一个家系2例患者携带纯合RNF216无义变异(c.2056C>T:p.Arg686*),表现为HH合并晚发性共济失调与痴呆。体外功能分析显示该变异及其他HH相关RNF216变异均破坏自噬调控,导致细胞活力下降和细胞死亡,且可被自噬抑制剂3-MA阻止,提示自噬介导的细胞死亡参与该综合征。

要点

  • HH合并晚发性共济失调和痴呆患者应警惕RNF216基因变异。
  • RNF216变异通过功能丧失破坏自噬调控,导致自噬介导的细胞死亡。
  • 自噬抑制剂3-MA可阻止RNF216变异相关细胞死亡,提示潜在干预方向。

核心结论

  • RNF216功能改变通过自噬介导的机制导致细胞死亡,参与HH合并共济失调与痴呆的发病。

研究设计与样本

  • 对单中心1476例HH患者队列进行外显子分析,并对鉴定的RNF216变异进行体外功能分析(自噬调控和细胞活力)。

主要发现

  • 在1476例患者中,一个家系2例患者携带纯合NM_207111.4:c.2056C>T:p.(Arg686*) RNF216变异,表现为HH合并晚发性共济失调与痴呆。
  • 表达该RNF216变异的细胞自噬调控被破坏,提示功能丧失效应。
  • 抑制RNF216表达降低细胞活力;Z-VAD不能保护细胞免于死亡,而3-MA可阻止细胞死亡。
  • 其他报道与该型HH相关的RNF216变异对自噬有类似功能影响。

关键数值与推荐

  • RNF216变异鉴定:NM_207111.4:c.2056C>T:p.(Arg686*),纯合状态,见于一个家系2例患者。
  • 功能实验:3-MA(自噬抑制剂)阻止细胞死亡,Z-VAD(pan-caspase抑制剂)未保护细胞。

临床怎么用

  • 对HH合并晚发性共济失调和痴呆的患者,可考虑RNF216基因检测以明确遗传病因。
  • RNF216相关综合征目前无特异性治疗,自噬调控通路可能为未来干预提供方向。

局限性

  • 研究基于单中心队列,RNF216变异在HH中可能罕见。
  • 机制证据主要来自体外功能实验,尚未在体内模型或临床干预中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hypogonadotropic hypogonadism (HH) with severe ataxia, impotence, and dementia has been reported in a handful of patients carrying RNF216 gene variants. However, the underlying molecular mechanism explaining this complex phenotype remains unclear to date. RNF216 encodes a "RING-between-RING"(RBR)-class E3 ubiquitin ligase. Among the targets of RNF216 is Beclin-1, a pivotal regulator of autophagy, particularly within the central nervous system. OBJECTIVES: (i) To assess the prevalence of RN216 mutations in a large cohort of patients with HH. (ii) To examine the impact on autophagy of identified RNF216 pathogenic variants. METHODS: Exome analysis in a monocentric cohort of patients with HH. In vitro functional analysis of RNF216 variants in the regulation of autophagy and cell viability. RESULTS: Among 1476 patients, we identified a unique NM_207111.4:c.2056C>T:p.(Arg686*) RNF216 variant in the homozygous state in one family with 2 affected patients presenting with HH associated with late-onset ataxia and dementia. We observed that in cells expressing this RNF216 variant, the regulation of autophagy was disrupted, indicating a loss-of-function effect. We demonstrated that inhibiting RNF216 expression decreased cell viability. Z-VAD, a pan-caspase inhibitor, did not protect cells from death, whereas 3-MA, an autophagy inhibitor, prevented cell death. Interestingly, we found that other RNF216 variants reported to be associated with this form of HH had a similar functional impact on autophagy. CONCLUSION: Our results suggest that alteration of RNF216 function leads to cell death through an autophagy-mediated mechanism which contributes to combined HH and ataxia and dementia in affected patients.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Young J, Abdennebi I, Le Saëc M, et al. RNF216 Variants Found in Patients With Dementia, Hypogonadotropic Hypogonadism, and Severe Ataxia Deregulate Autophagy. J Clin Endocrinol Metab. 2026. PMID: 41271602. doi:10.1210/clinem/dgaf640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。